NASDAQ:CNTX | Profit Breakdown | Context Therapeutics Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$14.97M-$14.56M
2026-03-31-$9.34M-$8.68M
2025-12-31-$13.8M-$13.03M
2025-09-30-$10.61M-$9.69M
2025-06-30-$9.76M-$8.83M
2025-03-31-$5.53M-$4.58M
2024-12-31-$4.31M-$3.34M
2024-09-30-$18.7M-$17.46M
2024-06-30-$3.09M-$2.25M
2024-03-31-$3.82M-$3.67M
2023-12-31-$6.93M-$6.77M
2023-09-30-$6.18M-$5.87M
2023-06-30-$5.29M-$5.01M
2023-03-31-$6.67M-$6.31M
2022-12-31-$3.88M-$3.56M
2022-09-30-$4.05M-$3.85M
2022-06-30-$4.01M-$3.99M
2022-03-31-$3.44M-$3.44M
2021-12-31-$3.09M-$3.09M
2021-09-30-$1.57M-$1.44M
2021-06-30-$5.03M-$5.03M
2021-03-31-$840,318.00-$892,049.00
2020-12-31-$769,544.00-$784,749.00
2020-09-30-$651,060.00-$876,237.00
2020-06-30$7.48M
2020-03-31$826,480.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$39.7M-$36.12M
2024-12-31-$29.92M-$26.73M
2023-12-31-$25.07M-$23.96M
2022-12-31-$15.38M-$14.84M
2021-12-31-$10.53M-$10.46M
2020-12-31-$2.57M$6.64M